Allarity Therapeutics, Inc. (ALLR) Operating income 2020–2025
Allarity Therapeutics, Inc. (ALLR) annual operating income history from SEC filings — each fiscal year as reported.
-$12.6MFY2025 · since FY2020: -$8.3M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | +53.7% |
| FY2024 | -$27.2M | -59.0% |
| FY2023 | -$17.1M | +50.3% |
| FY2022 | -$34.5M | -29.8% |
| FY2021 | -$26.6M | -219.2% |
| FY2020 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALLR financial trends
ALLR RevenueALLR Net incomeALLR Net marginALLR Gross profitALLR Gross marginALLR Operating marginALLR Operating cash flowALLR Free cash flowALLR Capital expendituresALLR Return on equityALLR Stock buybacksALLR Dividends paidALLR Total assetsALLR Total liabilitiesALLR Shareholders’ equityALLR overview →